Effect of vitamin D supplementation on the level of circulating high-sensitivity C-reactive protein: A meta-analysis of randomized controlled trials

Nutrients

Volumn 6, Issue 6, 2014, Pages 2206-2216

  Chen, Neng ^a   Wan, Zhongxiao ^a   Han, Shu Fen ^a   Li, Bing Yan ^b   Zhang, Zeng Li ^b   Qin, Li Qiang ^a  

^a SOOCHOW UNIVERSITY   (China)

^b MEDICAL COLLEGE OF SOOCHOW UNIVERSITY   (China)

Author keywords

Cardiovascular disease; High sensitivity C reactive protein (hs CRP); Meta analysis; Vitamin D

Indexed keywords

C REACTIVE PROTEIN; VITAMIN D;

CARDIOVASCULAR DISEASE; CORONARY ARTERY DISEASE; DATA EXTRACTION; GENETIC HETEROGENEITY; HEALTH STATUS; HUMAN; META ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OVARY POLYCYSTIC DISEASE; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REGRESSION ANALYSIS; REVIEW; SENSITIVITY ANALYSIS; VITAMIN SUPPLEMENTATION; METABOLISM;

C-REACTIVE PROTEIN; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; VITAMIN D;

EID: 84902311373     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu6062206     Document Type: Review

References (33)

1. McGreevy, C.; Williams, D. New insights about vitamin D and cardiovascular disease. Ann. Int. Med. 2011, 155, 820-826.
2. Rifai, N.; Ridker, P.M. High-Sensitivity C-reactive protein: A novel and promising marker of coronary heart disease. Clin. Chem. 2001, 47, 403-411.
3. De Ferranti, S.D.; Rifai, N. C-reactive protein: A nontraditional serum marker of cardiovascular risk. Cardiovasc. Pathol. 2007, 16, 14-21.
4. Kaptoge, S.; di Angelantonio, E.; Pennells, L.; Wood, A.M.; White, I.R.; Gao, P.; Walker, M.; Thompson, A.; Sarwar, N.; Caslake, M., et al. C-reactive protein, fibrinogen, and cardiovascular disease prediction. N. Eng. J. Med. 2012, 367, 1310-1320.
5. Guillot, X.; Semerano, L.; Saidenberg-Kermanac'h, N.; Falgarone, G.; Boissier, M.C. Vitamin D and inflammation. Joint Bone Spine 2010, 77, 552-557.
6. Zanetti, M.; Harris, S.S.; Dawson-Hughes, B. Ability of vitamin D to reduce inflammation in adults without acute illness. Nutr. Rev. 2014, 72, 95-98.
7. Moher, D.; Liberati, A.; Tetzlaff, J.; Altman, D.G.; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. Ann. Int. Med. 2009, 151, 264-269.
8. Jadad, A.R.; Moore, R.A.; Carroll, D.; Jenkinson, C.; Reynolds, D.J.; Gavaghan, D.J.; McQuay, H.J. Assessing the quality of reports of randomized clinical trials: Is blinding necessary? Control Clin. Trials 1996, 17, 1-12.
9. Whitlock, R.P.; Chan, S.; Devereaux, P.J.; Sun, J.; Rubens, F.D.; Thorlund, K.; Teoh, K.H. Clinical benefit of steroid use in patients undergoing cardiopulmonary bypass: A meta-analysis of randomized trials. Eur. Heart J. 2008, 29, 2592-2600.
10. Higgins, J.P.; Thompson, S.G.; Deeks, J.J.; Altman, D.G. Measuring inconsistency in meta-analyses. BMJ 2003, 327, 557-560.
11. DerSimonian, R.; Laird, N.P. Meta-analysis in clinical trials. Control. Clin. Trials 1986, 7, 177-188.
12. Egger, M.; Davey, S.G.; Schneider, M.; Minder, C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997, 315, 629-634.
13. Chandler, P.D.; Scott, J.B.; Drake, B.F.; Ng, K.; Manson, J.E.; Rifa, N.; Chan, A.T.; Bennett, G.G.; Hollis, B.W.; Giovannucci, E.L., et al. Impact of vitamin D supplementation on inflammatory markers in African Americans: Results of a four-arm, randomized, placebo-controlled trial. Cancer Prev. Res. 2014, 7, 218-225.
14. Asemi, Z.; Samimi, M.; Tabassi, Z.; Shakeri, H.; Esmaillzadeh, A. Vitamin D supplementation affects serum high-sensitivity C-reactive protein, insulin resistance, and biomarkers of oxidative stress in pregnant women. J. Nutr. 2013, 143, 1432-1438.
15. Breslavsky, A.; Frand, J.; Frand, Z.; Boaz, M.; Barnea, Z.; Shargorodsky, M. Effect of high doses of vitamin D on arterial properties, adiponectin, leptin and glucose homeostasis in type 2 diabetic patients. Clin. Nutr. 2013, 32, 970-975.
16. Rahimi-Ardabili, H.; Pourghassem, G.B.; Farzadi, L. Effects of vitamin D on cardiovascular disease risk factors in polycystic ovary syndrome women with vitamin D deficiency. J. Endocrinol. Investig. 2013, 36, 28-32.
17. Wamberg, L.; Kampmann, U.; Stødkilde-Jørgensen, H.; Rejnmark, L.; Pedersen, S.B.; Richelsen, B. Effects of vitamin D supplementation on body fat accumulation, inflammation, and metabolic risk factors in obese adults with low vitamin D levels-Results from a randomized trial. Eur. J. Int. Med. 2013, 24, 644-649.
18. Shab-Bidar, S.; Neyestani, T.R.; Djazayery, A.; Eshraghian, M.R.; Houshiarrad, A.; Kalayi, A.; Shariatzadeh, N.; Khalaji, N.; Gharavi, A. Improvement of vitamin D status resulted in amelioration of biomarkers of systemic inflammation in the subjects with type 2 diabetes. Diabetes Metab. Res. Rev. 2012, 28, 424-430.
19. Sokol, S.I.; Srinivas, V.; Crandall, J.P.; Kim, M.; Tellides, G.; Lebastchi, A.H.; Yu, Y.; Gupta, A.K.; Alderman, M.H. The effects of vitamin D repletion on endothelial function and inflammation in patients with coronary artery disease. Vasc. Med. 2012, 17, 394-404.
20. Jorde, R.; Sneve, M.; Torjesen, P.A.; Figenschau, Y.; Gøransson, L.G.; Omdal, R. No effect of supplementation with cholecalciferol on cytokines and markers of inflammation in overweight and obese subjects. Cytokine 2010, 50, 175-180.
21. Von Hurst, P.R.; Stonehouse, W.; Coad, J. Vitamin D supplementation reduces insulin resistance in South Asian women living in New Zealand who are insulin resistant and vitamin D deficient-A randomized, placebo-controlled trial. Br. J. Nutr. 2010, 103, 549-555.
22. Bjorkman, M.P.; Sorva, A.J.; Tilvis, R.S. C-reactive protein and fibrinogen of bedridden older patients in a six-month vitamin D supplementation trial. J. Nutr. Health Aging 2009, 13, 435-439.
23. Agrawal, A.; Cha-Molstad, H.; Samols, D.; Kushner, I. Overexpressed nuclear factor-kappaB can participate in endogenous C-reactive protein induction, and enhances the effects of C/EBPbeta and signal transducer and activator of transcription-3. Immunology 2003, 108, 539-547.
24. Cohen-Lahav, M.; Shany, S.; Tobvin, D.; Chaimovitz, C.; Douvdevani, A. Vitamin D decreases NFκB activity by increasing IkappaBalpha levels. Nephrol. Dial. Transplant. 2006, 21, 889-897.
25. Song, Y.; Hong, J.; Liu, D.; Lin, Q.; Lai, G. 1,25-Dihydroxyvitamin D3 inhibits nuclear factor kappa B activation by stabilizing inhibitor IκBα via mRNA stability and reduced phosphorylation in passively sensitized human airway smooth muscle cells. Scand. J. Immunol. 2013, 77, 109-116.
26. Wang, Q.; Li, H.; Xie, H.; Fu, M.; Guo, B.; Ding, Y.; Li, W.; Yu, H. 25-Hydroxyvitamin D3 attenuates experimental periodontitis through downregulation of TLR4 and JAK1/STAT3 signaling in diabetic mice. J. Steroid Biochem. Mol. Biol. 2013, 135, 43-50.
27. Ngo, D.T.; Sverdlov, A.L.; McNeil, J.J.; Horowitz, J.D. Does vitamin D modulate asymmetric dimethylarginine and C-reactive protein concentrations? Am. J. Med. 2010, 123, 335-341.
28. Bellia, A.; Garcovich, C.; D'Adamo, M.; Lombardo, M.; Tesauro, M.; Donadel, G.; Gentileschi, P.; Lauro, D.; Federici, M.; Lauro, R., et al. Serum 25-hydroxyvitamin D levels are inversely associated with systemic inflammation in severe obese subjects. Int. Emerg. Med. 2013, 8, 33-40.
29. Amer, M.; Qayyum, R. Relation between serum 25-hydroxyvitamin D and C-reactive protein in asymptomatic adults (from the continuous National Health and Nutrition Examination Survey 2001 to 2006). Am. J. Cardiol. 2012, 109, 226-230.
30. Wacker, M.; Holick, M.F. Sunlight and Vitamin D: A global perspective for health. Dermatoendocrinology 2013, 5, 51-108.
31. DRI Tables Food and Nutrition Information Center. Available online: https://fnic.nal.usda.gov/dietary-guidance/dietary-reference-intakes/dri-tables (accessed on 17 March 2014).
32. Holick, M.F.; Binkley, N.C.; Bischoff-Ferrari, H.A.; Gordon, C.M.; Hanley, D.A.; Heaney, R.P. Evaluation, treatment, and prevention of vitamin D deficiency: An Endocrine Society clinical practice guideline. J. Clin. Endocrinol. Metab. 2011, 96, 1911-1930.
33. Romagnoli, E.; Pepe, J.; Piemonte, S.; Cipriani, C.; Minisola, S. Management of endocrine disease: Value and limitations of assessing vitamin D nutritional status and advised levels of vitamin D supplementation. Eur. J. Endocrinol. 2013, 169, R59-R69.